Connor, Clark & Lunn Investment Management (CC&L)
RPTP

Connor, Clark & Lunn Investment Management (CC&L)’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-18,400
Closed -$99K – 988
2016
Q2 		$99K Sell
18,400
-32,700
-64% -$168K ﹤0.01% 803
2016
Q1 		$235K Sell
51,100
-16,100
-24% -$64.7K ﹤0.01% 693
2015
Q4 		$349K Buy
+67,200
New +$390K ﹤0.01% 605

Other funds holding RPTP

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s RPTP Position: Q3 2016 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 18,400 shares — an estimated $99K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in RPTP in Q4 2015 and held it in 3 quarters. The position peaked at $349K in Q4 2015. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 18,400 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $99K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2015 and held it in 3 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $349K in Q4 2015.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2016, filed 15 Nov 2016.